IRTC vs. SNN, SOLV, PEN, STVN, GKOS, NARI, TMDX, BLCO, INSP, and SLNO
Should you be buying iRhythm Technologies stock or one of its competitors? The main competitors of iRhythm Technologies include Smith & Nephew (SNN), Solventum (SOLV), Penumbra (PEN), Stevanato Group (STVN), Glaukos (GKOS), Inari Medical (NARI), TransMedics Group (TMDX), Bausch + Lomb (BLCO), Inspire Medical Systems (INSP), and Soleno Therapeutics (SLNO). These companies are all part of the "medical equipment" industry.
iRhythm Technologies vs.
Smith & Nephew (NYSE:SNN) and iRhythm Technologies (NASDAQ:IRTC) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their community ranking, analyst recommendations, media sentiment, earnings, institutional ownership, valuation, profitability, risk and dividends.
Smith & Nephew received 35 more outperform votes than iRhythm Technologies when rated by MarketBeat users. However, 66.24% of users gave iRhythm Technologies an outperform vote while only 54.10% of users gave Smith & Nephew an outperform vote.
Smith & Nephew currently has a consensus price target of $28.00, suggesting a potential downside of 6.90%. iRhythm Technologies has a consensus price target of $133.73, suggesting a potential downside of 9.97%. Given Smith & Nephew's higher possible upside, analysts clearly believe Smith & Nephew is more favorable than iRhythm Technologies.
Smith & Nephew has a net margin of 0.00% compared to iRhythm Technologies' net margin of -19.14%. Smith & Nephew's return on equity of 0.00% beat iRhythm Technologies' return on equity.
Smith & Nephew has a beta of 0.68, meaning that its stock price is 32% less volatile than the S&P 500. Comparatively, iRhythm Technologies has a beta of 1.4, meaning that its stock price is 40% more volatile than the S&P 500.
In the previous week, Smith & Nephew had 2 more articles in the media than iRhythm Technologies. MarketBeat recorded 7 mentions for Smith & Nephew and 5 mentions for iRhythm Technologies. Smith & Nephew's average media sentiment score of 0.75 beat iRhythm Technologies' score of 0.55 indicating that Smith & Nephew is being referred to more favorably in the media.
25.6% of Smith & Nephew shares are held by institutional investors. 1.0% of Smith & Nephew shares are held by insiders. Comparatively, 1.1% of iRhythm Technologies shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.
Smith & Nephew has higher revenue and earnings than iRhythm Technologies. iRhythm Technologies is trading at a lower price-to-earnings ratio than Smith & Nephew, indicating that it is currently the more affordable of the two stocks.
Summary
Smith & Nephew beats iRhythm Technologies on 12 of the 18 factors compared between the two stocks.
Get iRhythm Technologies News Delivered to You Automatically
Sign up to receive the latest news and ratings for IRTC and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartMedia Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
iRhythm Technologies Competitors List
Related Companies and Tools
This page (NASDAQ:IRTC) was last updated on 6/10/2025 by MarketBeat.com Staff